14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today CTRV ranks #18840 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

ContraVir Pharmaceuticals Inc Stock Forecast NASDAQ:CTRV

$1.01 (-3.81%)

Volume: 557k

Closed: Jan 21, 2022

Hollow Logo Score: -6.157

ContraVir Pharmaceuticals Inc Stock Forecast

$1.01 (-3.81%)

Volume: 557k

Closed: Jan 21, 2022

Score Hollow Logo -6.157

ContraVir Pharmaceuticals Inc Company Profile

399 Thornall Street

Edison NJ 08837



ContraVir Pharmaceuticals Inc


ContraVir Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development of antiviral drugs with a primary emphasis on the treatment of Hepatitis B virus (HBV) infections. The company is developing CMX157 and CRV431 to treat HBV infection; and FV-100, an orally available, small molecule compound for the prevention of post-herpetic neuralgia, and treatment of herpes zoster infection and acute zoster-associated pain. ContraVir Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Edison, New Jersey.

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE